Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PIPITONE, Rosaria Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.090
EU - Europa 3.236
AS - Asia 2.920
SA - Sud America 476
AF - Africa 88
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.963
SG - Singapore 1.072
RU - Federazione Russa 872
IT - Italia 857
CN - Cina 745
BR - Brasile 378
FI - Finlandia 353
HK - Hong Kong 282
VN - Vietnam 257
DE - Germania 233
PL - Polonia 168
UA - Ucraina 148
FR - Francia 134
GB - Regno Unito 126
IE - Irlanda 114
IN - India 96
BD - Bangladesh 84
JP - Giappone 84
KR - Corea 80
CA - Canada 58
SE - Svezia 52
AR - Argentina 40
TR - Turchia 37
IQ - Iraq 33
NL - Olanda 33
AT - Austria 28
MX - Messico 28
ID - Indonesia 23
RO - Romania 23
AU - Australia 22
CI - Costa d'Avorio 20
ZA - Sudafrica 18
CL - Cile 16
ES - Italia 15
JM - Giamaica 15
SA - Arabia Saudita 15
BE - Belgio 14
GR - Grecia 14
EC - Ecuador 13
IR - Iran 13
PK - Pakistan 13
UZ - Uzbekistan 12
EG - Egitto 11
PH - Filippine 11
LT - Lituania 10
CO - Colombia 9
JO - Giordania 9
AZ - Azerbaigian 8
HN - Honduras 7
BG - Bulgaria 6
BY - Bielorussia 6
MA - Marocco 6
MY - Malesia 6
NP - Nepal 6
PY - Paraguay 6
TN - Tunisia 6
AL - Albania 5
DZ - Algeria 5
LB - Libano 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
NG - Nigeria 4
NI - Nicaragua 4
PA - Panama 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
CZ - Repubblica Ceca 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
OM - Oman 3
PR - Porto Rico 3
SN - Senegal 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
GD - Grenada 1
GI - Gibilterra 1
Totale 13.825
Salva come PNG Salva come JPEG
Città #
Ashburn 890
Fairfield 879
Singapore 774
Woodbridge 407
Chandler 377
Houston 375
San Jose 363
Seattle 331
Wilmington 324
Cambridge 286
Hong Kong 263
Palermo 249
Ann Arbor 205
Moscow 155
Zgierz 141
Des Moines 121
Beijing 118
Dublin 111
New York 109
Ho Chi Minh City 105
Los Angeles 104
Santa Clara 103
Medford 99
Helsinki 96
Council Bluffs 91
Dallas 78
Frankfurt am Main 75
Tokyo 75
The Dalles 72
Boardman 70
Jacksonville 69
Altamura 68
Lauterbourg 66
Princeton 65
Nanjing 64
Hanoi 63
Lawrence 61
Hefei 52
Rome 51
Chicago 45
San Diego 40
Buffalo 37
Milan 35
São Paulo 31
London 30
Dearborn 29
Shenyang 29
Orem 28
Jinan 26
Seoul 25
Changsha 23
Nuremberg 23
Mumbai 22
Tulsa 22
Atlanta 21
Chennai 21
Jiaxing 21
Abidjan 20
Phoenix 20
San Paolo di Civitate 20
Brooklyn 19
Hebei 19
Washington 19
Montreal 18
Nanchang 18
Warsaw 17
Baghdad 16
Denver 16
Guangzhou 16
Ludwigshafen am Rhein 16
Izmir 15
Stockholm 15
Zhengzhou 15
Shanghai 14
Athens 13
Brussels 13
Belo Horizonte 12
Brasília 12
Kumar 12
Amsterdam 11
Haiphong 11
Johannesburg 11
Ningbo 11
Porto Alegre 11
Redondo Beach 11
Paris 10
Saint Petersburg 10
Tianjin 10
Amman 9
Boston 9
Central 9
Redwood City 9
Seongnam 9
Ankara 8
Baku 8
Bari 8
Da Nang 8
Kingston 8
Taizhou 8
Tashkent 8
Totale 9.065
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 396
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 311
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 298
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 297
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 296
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 280
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 274
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 257
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 256
MAFLD: a multisystem disease 250
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 249
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 246
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 243
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 240
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 235
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 233
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides 231
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 230
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 227
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES 224
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 223
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 222
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 222
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity 221
Genetic predisposition to thrombophilia in inflammatory bowel disease 218
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 217
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. 214
Correlation between the single nucleotide polymorphism (SNP) rs4374383 in MERTK gene with the risk of development and progression of liver disease 213
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. 212
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides 209
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. 208
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors 203
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity 200
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 199
Statin use and non-alcoholic steatohepatitis in at risk individuals 197
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 196
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 193
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 184
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 182
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 182
Novel Terphenyls and 3,5-Diaryl Isoxazole Derivatives Endowed with Growth Supporting and Antiapoptotic Properties 178
EPIGENETIC PROFILING AND THERAPEUTICS IN LIVER DISEASE 167
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. 164
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis 164
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 163
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 161
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease 160
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line 154
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. 154
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis 154
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease 154
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study 151
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 150
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 149
The PD-1/PD-L1 Axis in the Biology of MASLD 147
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 144
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 143
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 143
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization 139
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] 138
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. 135
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 132
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population 131
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C 127
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization 123
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 123
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development 119
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 119
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease 117
Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4α, Lepr, and GK expression 114
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity 110
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease 109
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 100
Liver follicular helper T-cells in chronic hepatitis C 76
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 74
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity" 12
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 1
Totale 14.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022891 57 187 25 29 23 32 50 59 94 114 76 145
2022/20231.187 107 240 23 113 107 196 104 80 125 7 55 30
2023/2024554 19 66 27 46 62 143 37 51 6 23 23 51
2024/20251.536 38 88 99 149 53 47 179 95 97 191 212 288
2025/20265.475 402 147 314 454 556 788 827 567 394 533 240 253
2026/2027112 112 0 0 0 0 0 0 0 0 0 0 0
Totale 14.187